Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Sofosbuvir And Velpatasvir, Atc J05Ap55 For The Period May 1, 2024 - April 30, 2026

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 79779349

  Document Type - Tender Notices

Description - Description Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With reg ard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicinal products to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, sofosbuvir and velpatasvir, ATC J05AP55, DAK-Gesundheit intends to conclude drug discount

Gt Ref Id - 79779349

Deadline - Mar 05, 2026